Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06083896 · ClinicalTrials.gov registry record · Phase 1
Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-center Prospective Study of Functional Outcome
A Phase 1 study of Pelvic Metastasis, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06083896 is a Phase 1 study of Pelvic Metastasis that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06083896, a Phase 1 study of Pelvic Metastasis, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Determine whether patients exhibit early functional improvement after minimally-invasive placement of Illuminoss photodynamic nails for peri-acetabular pelvic metastasis at 3 months following procedure
Conditions Studied
Interventions
- PROCEDURE Photodynamic nails
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-10-06 |
| Est. Completion | 2029-01-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06083896
The ClinicalTrials.gov registry entry for NCT06083896 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pelvic Metastasis appearing as the primary indexed condition, and to 1 intervention - of which Photodynamic nails is the first listed.
NCT06083896 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06083896 about?
NCT06083896 is a clinical study titled "Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-center Prospective Study of Functional Outcome". Determine whether patients exhibit early functional improvement after minimally-invasive placement of Illuminoss photodynamic nails for peri-acetabular pelvic metastasis at 3 months following procedure
What is the current status of trial NCT06083896?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2023-10-06. Estimated completion is 2029-01-01.
What conditions does trial NCT06083896 study?
This clinical trial studies the following conditions: Pelvic Metastasis.
What interventions are being tested in trial NCT06083896?
The interventions under investigation include: Photodynamic nails (PROCEDURE).
Who is sponsoring clinical trial NCT06083896?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06083896 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.